A note in support of reversal treatment for coronary artery disease.
Coronary heart disease is the leading cause of mortality and morbidity in the United States at an estimated cost of $56 billion per year. Current approaches to treatment of coronary artery disease are not likely to reduce mortality and morbidity despite pressure to reduce costs in the changing health care environment. Evidence is now available that comprehensive noninvasive medical management, which includes aggressive lipid-lowering therapy, can produce results equivalent to current approaches at a lower cost. The author supports this approach, which can prevent progression and possibly produce regression of coronary artery disease. A new approach to management is proposed that integrates comprehensive noninvasive management as initial therapy for coronary heart disease.
Lane
D M
DM
D015906:Angioplasty, Balloon, Coronary / Q000191:economics; D003131:Combined Modality Therapy; D001026:Coronary Artery Bypass / Q000191:economics; D003327:Coronary Disease / Q000191:economics / Q000453:epidemiology / Q000628:therapy*; D003365:Costs and Cost Analysis; D004036:Diet, Atherogenic; D015438:Health Behavior; D006801:Humans; D015994:Incidence; D009017:Morbidity; D012680:Sensitivity and Specificity